DMIIU|Drugs Made In America Acquisition II Units|Price:10.160|

More Details of Company

Drugs Made In America Acquisition II Units Info



Ticker Symbol- -

Company name- -

IPO date- -

CEO- -

Number of employees- -

Security type- -

Fiscal year-end- -

Address- -

City- -

Stock exchange- -

Country- -

Postal code- -

Phone- -

Website- -

Ticker Symbol- -

IPO date- -

CEO- -

Company Executives of Drugs Made In America Acquisition II Units



Name

Name/Position

Position

Shareholding

Change

Ms. Lynn Stockwell

Executive Chairman of the Board, Chief Executive Officer

--

Mr. Glenn Worman

Chief Financial Officer, Principal Financial and Accounting Officer

--

Dr. Catherine Do

Independent Director

--

Dr. G. Sridhar Prasad

Independent Director

--

Mr. Myron W. Shulgan

Independent Director

--

Mr. Saleem Elmasri, CPA

Chief Financial Officer, Principal Financial and Accounting Officer

--

Name

Name/Position

Position

Shareholding

Change

Ms. Lynn Stockwell

Executive Chairman of the Board, Chief Executive Officer

--

Mr. Glenn Worman

Chief Financial Officer, Principal Financial and Accounting Officer

--

Dr. Catherine Do

Independent Director

--

Dr. G. Sridhar Prasad

Independent Director

--

Mr. Myron W. Shulgan

Independent Director

--

Mr. Saleem Elmasri, CPA

Chief Financial Officer, Principal Financial and Accounting Officer

--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

By Business

By Region

Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Wed, Dec 10

Shareholders

Shareholder Types

Shareholders

Proportion

Magnetar Capital Partners LP

4.12%

MMCAP Asset Management

4.12%

Glazer Capital, LLC

3.58%

LMR Partners LLP

3.05%

Millennium Management LLC

3.05%

Other

82.08%

Shareholders

Proportion

Magnetar Capital Partners LP

4.12%

MMCAP Asset Management

4.12%

Glazer Capital, LLC

3.58%

LMR Partners LLP

3.05%

Millennium Management LLC

3.05%

Other

82.08%

Shareholder Types

Shareholders

Proportion

Hedge Fund

39.46%

Investment Advisor/Hedge Fund

16.55%

Investment Advisor

7.62%

Pension Fund

5.18%

Research Firm

1.42%

Corporation

1.07%

Bank and Trust

0.20%

Other

28.49%

Institutional Shareholding



Updated: Tue, Dec 9

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

78

46.21M

0.02%

--

2025Q3

76

45.95M

70.07%

+45.95M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Magnetar Capital Partners LP

2.70M

4.12%

+2.70M

--

Sep 30, 2025

MMCAP Asset Management

2.70M

4.12%

+2.70M

--

Sep 30, 2025

Glazer Capital, LLC

2.35M

3.58%

+2.35M

--

Sep 30, 2025

LMR Partners LLP

2.00M

3.05%

+2.00M

--

Sep 30, 2025

Millennium Management LLC

2.00M

3.05%

+2.00M

--

Sep 30, 2025

Healthcare Of Ontario Pension Plan

2.00M

3.05%

+2.00M

--

Sep 30, 2025

Hudson Bay Capital Management LP

1.97M

3%

+1.97M

--

Sep 30, 2025

First Trust Capital Management L.P.

1.88M

2.87%

+1.88M

--

Sep 30, 2025

Tenor Capital Management Co., L.P.

1.50M

2.29%

+1.50M

--

Sep 30, 2025

Polar Asset Management Partners Inc.

1.50M

2.29%

+1.50M

--

Sep 30, 2025

Related ETFs



Updated: Tue, Dec 9

Name

Proportion

SPAC and New Issue ETF

0%

SPAC and New Issue ETF

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data